Imaging in Chronic Obstructive Pulmonary Disease: Ready for Prime Time?

Area of Science:

• Pulmonary Medicine
• Radiology
• Medical Imaging

Background:

• Chronic obstructive pulmonary disease (COPD) is a significant global health issue with over 392 million affected individuals.
• Spirometry, while standard for diagnosing airflow limitation, does not fully capture the disease's heterogeneity.
• Smokers with normal spirometry can still have significant lung abnormalities.

Purpose of the Study:

• To highlight the role of advanced imaging techniques in assessing COPD.
• To demonstrate how imaging can provide a more comprehensive understanding of COPD's structural, functional, and inflammatory aspects.
• To discuss the potential of imaging as a core component in COPD research and clinical practice.

Main Methods:

• Quantitative CT (QCT) for emphysema metrics (e.g., 15th percentile lung density, mean lung density, low-attenuation area percentage).
• Parametric response mapping and voxel-based indices for small airway disease and gas trapping.
• Advanced MRI and ^18F-FDG PET for radiation-free insights and inflammatory assessment.
• Analysis of airway remodeling metrics (e.g., Pi10, PiSlope) and mucus plug burden.

Main Results:

• QCT metrics are reproducible, sensitive to progression, and valuable outcome measures.
• Imaging can characterize small airway disease, mechanically affected lung regions, and airway remodeling.
• Mucus plug burden is an independent predictor of mortality and a potential surrogate endpoint.
• Advanced MRI and PET offer complementary, non-invasive insights into COPD pathology.

Conclusions:

• Advanced imaging techniques provide a comprehensive assessment of COPD, surpassing spirometry's limitations.
• Imaging metrics offer prognostic information and can identify potential therapeutic targets.
• Imaging is poised to transition from an adjunct tool to a central element in COPD research and patient management.